DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Novartis International AG.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS).
(last accessed Dec 15 2014).
http://hugin.info/134323/R/1875463/660871.pdf 2014
We do not assume any responsibility for the contents of the web pages of other providers.